Skip to menu Skip to content Skip to footer
News

How the brain’s recycling system breaks down in Parkinson’s Disease

24 February 2023
a woman with short grey hair looks to the left on a black background, a white superimposed drawing of a brain is on her head
Image: Adobe

Researchers from the University of Queensland have identified that a gene associated with an increased risk of Parkinson’s Disease also contributes to a build-up of cell debris in the brain.

Dr Adekunle Bademosi from The Queensland Brain Institute said the discovery could change the focus of Parkinson’s Disease treatment.

“Our team has found that a Parkinson’s Disease-linked mutation in a gene called Endophilin A1 blocks the process by which the body and the brain recycle cell waste,” Dr Bademosi said.

Without the process, called autophagy, toxic debris builds up and neurons die – known hallmarks of Parkinson’s Disease.

“We knew we could induce autophagy in cells by starving them of amino acids and the subsequent breakdown of debris tells a protein called EndoA to approach the cell membrane and begin the recycling process,” Dr Bademosi said.

“Now we’ve also seen that regular signals between neurons in the brain starts EndoA-induced autophagy when the electric impulses trigger the release of proteins or neurotransmitters at synapses.

“Unfortunately, when the Endophilin A1 gene is affected in Parkinson’s, the protein EndoA becomes insensitive to this trigger at the synapse and the debris that should be thrown out for recycling builds up instead.”

Decorative
Current Parkinson’s treatments tend to focus on clearing out the build-ups and replacing what is lost when too many neurons die.

“It may be time to shift the treatment focus to autophagy as the mechanism underlying these disease hallmarks,” Dr Bademosi said.

“Exploring the use of compounds that induce or inhibit autophagy could pave the way for new, more effective Parkinson’s drugs.”

UQ acknowledges the collaborative efforts of researchers in Professor Patrik Verstreken’s lab at the Flanders Institute of Biotechnology (VIB) in Belgium.

This study was published in Neuron.

Image above left: Dr Adekunle Bademosi.

Media: QBI Communications, communications@qbi.uq.edu.au, Elaine Pye +61 415 222 606, Merrett Pye +61 422 096 049.

Related articles

Close up of two young men facing each other

Nature versus nurture question addressed in landmark study

Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and susceptibility to diseases like Type 2 diabetes, in a study co-led by UQ researchers and collaborators at genomic technology company Illumina, Inc.
13 November 2025
Female doctor taking blood pressure of female patient in clinic.

A better way to assess cardiovascular health

Lower body mass index (BMI), blood pressure and cholesterol were not always the most important factors when considering a person’s overall risk of dying, University of Queensland research has concluded.
10 November 2025

Media contact

Subscribe to UQ News

Get the latest from our newsroom.